182 related articles for article (PubMed ID: 38753434)
41. New era of biologic therapeutics in atopic dermatitis.
Guttman-Yassky E; Dhingra N; Leung DY
Expert Opin Biol Ther; 2013 Apr; 13(4):549-61. PubMed ID: 23323893
[TBL] [Abstract][Full Text] [Related]
42. Proteomic characterization of atopic dermatitis blood from infancy to adulthood.
Del Duca E; Renert-Yuval Y; Pavel AB; Mikhaylov D; Wu J; Lefferdink R; Fang M; Sheth A; Blumstein A; Facheris P; Estrada YD; Rangel SM; Krueger JG; Paller AS; Guttman-Yassky E
J Am Acad Dermatol; 2023 May; 88(5):1083-1093. PubMed ID: 36773824
[TBL] [Abstract][Full Text] [Related]
43. Comparative proteomic analysis of peripheral blood mononuclear cells from atopic dermatitis patients and healthy donors.
Kim WK; Cho HJ; Ryu SI; Hwang HR; Kim DH; Ryu HY; Chung JW; Kim TY; Park BC; Bae KH; Ko Y; Lee SC
BMB Rep; 2008 Aug; 41(8):597-603. PubMed ID: 18755076
[TBL] [Abstract][Full Text] [Related]
44. Proteomic analysis of bacterial communities associated with atopic dermatitis.
Kandil A; Hanora A; Azab M; Enany S
J Proteomics; 2020 Oct; 229():103944. PubMed ID: 32822829
[TBL] [Abstract][Full Text] [Related]
45. Recent Advancements in the Atopic Dermatitis Mechanism.
Savva M; Papadopoulos NG; Gregoriou S; Katsarou S; Papapostolou N; Makris M; Xepapadaki P
Front Biosci (Landmark Ed); 2024 Feb; 29(2):84. PubMed ID: 38420827
[TBL] [Abstract][Full Text] [Related]
46. Biomarkers in atopic dermatitis-a review on behalf of the International Eczema Council.
Renert-Yuval Y; Thyssen JP; Bissonnette R; Bieber T; Kabashima K; Hijnen D; Guttman-Yassky E
J Allergy Clin Immunol; 2021 Apr; 147(4):1174-1190.e1. PubMed ID: 33516871
[TBL] [Abstract][Full Text] [Related]
47. Atopic dermatitis endotypes: knowledge for personalized medicine.
Kim J; Ahn K
Curr Opin Allergy Clin Immunol; 2022 Jun; 22(3):153-159. PubMed ID: 35152229
[TBL] [Abstract][Full Text] [Related]
48. JAK1 inhibitors for the treatment of atopic dermatitis: a focus on pharmacokinetic considerations.
Kopelman H; Kontzias C; Alihosseni C; Feldman SR
Expert Opin Drug Metab Toxicol; 2023; 19(8):537-542. PubMed ID: 37695699
[TBL] [Abstract][Full Text] [Related]
49. An update on the topical and oral therapy options for treating pediatric atopic dermatitis.
Glines KR; Stiff KM; Freeze M; Cline A; Strowd LC; Feldman SR
Expert Opin Pharmacother; 2019 Apr; 20(5):621-629. PubMed ID: 30601075
[TBL] [Abstract][Full Text] [Related]
50. Multiple Roles for Cytokines in Atopic Dermatitis: From Pathogenic Mediators to Endotype-Specific Biomarkers to Therapeutic Targets.
Fania L; Moretta G; Antonelli F; Scala E; Abeni D; Albanesi C; Madonna S
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269828
[TBL] [Abstract][Full Text] [Related]
51. Atopic dermatitis phenotypes and the need for personalized medicine.
Cabanillas B; Brehler AC; Novak N
Curr Opin Allergy Clin Immunol; 2017 Aug; 17(4):309-315. PubMed ID: 28582322
[TBL] [Abstract][Full Text] [Related]
52. The Intestinal and Skin Microbiome in Patients with Atopic Dermatitis and Their Influence on the Course of the Disease: A Literature Review.
Mazur M; Tomczak H; Łodyga M; Plagens-Rotman K; Merks P; Czarnecka-Operacz M
Healthcare (Basel); 2023 Mar; 11(5):. PubMed ID: 36900771
[TBL] [Abstract][Full Text] [Related]
53. Age of onset defines two distinct profiles of atopic dermatitis in adults.
Facheris P; Da Rosa JC; Pagan AD; Angelov M; Del Duca E; Rabinowitz G; Gómez-Arias PJ; Rothenberg-Lausell C; Estrada YD; Bose S; Chowdhury M; Shemer A; Pavel AB; Guttman-Yassky E
Allergy; 2023 Aug; 78(8):2202-2214. PubMed ID: 37032461
[TBL] [Abstract][Full Text] [Related]
54. Mild atopic dermatitis lacks systemic inflammation and shows reduced nonlesional skin abnormalities.
He H; Del Duca E; Diaz A; Kim HJ; Gay-Mimbrera J; Zhang N; Wu J; Beaziz J; Estrada Y; Krueger JG; Pavel AB; Ruano J; Guttman-Yassky E
J Allergy Clin Immunol; 2021 Apr; 147(4):1369-1380. PubMed ID: 33011244
[TBL] [Abstract][Full Text] [Related]
55. Toward Precision Medicine in Atopic Dermatitis Using Molecular-Based Approaches.
Carrascosa-Carrillo JM; Aterido A; Li T; Guillén Y; Martinez S; Marsal S; Julià A
Actas Dermosifiliogr; 2024 Jan; 115(1):T66-T75. PubMed ID: 37923065
[TBL] [Abstract][Full Text] [Related]
56. Toward Precision Medicine in Atopic Dermatitis Using Molecular-Based Approaches.
Carrascosa-Carrillo JM; Aterido A; Li T; Guillén Y; Martinez S; Marsal S; Julià A
Actas Dermosifiliogr; 2024 Jan; 115(1):66-75. PubMed ID: 37652096
[TBL] [Abstract][Full Text] [Related]
57. Diversity of atopic dermatitis and selection of immune targets.
Rothenberg-Lausell C; Bar J; Del Duca E; Guttman-Yassky E
Ann Allergy Asthma Immunol; 2024 Feb; 132(2):177-186. PubMed ID: 38008215
[TBL] [Abstract][Full Text] [Related]
58. Testing biologics and intracellular signaling inhibitors on pediatric atopic dermatitis: a stairway to modern therapeutic approaches.
Chiricozzi A; Peroni D; Girolomoni G
Expert Opin Investig Drugs; 2018 Sep; 27(9):699-707. PubMed ID: 30142984
[TBL] [Abstract][Full Text] [Related]
59. Investigation of possible relationship between atopic dermatitis and salivary biomarkers, stress, and sleep disorders.
Estefan J; Ferreira DC; Cavalcante FS; Dos Santos KRN; Ribeiro M
World J Clin Cases; 2023 Jun; 11(17):3958-3966. PubMed ID: 37388791
[TBL] [Abstract][Full Text] [Related]
60. Proteomic analysis from skin swabs reveals a new set of proteins identifying skin impairment in atopic dermatitis.
Morelli P; Gaspari M; Gabriele C; Dastoli S; Bennardo L; Pavel AB; Patruno C; Del Duca E; Nisticò SP
Exp Dermatol; 2021 Jun; 30(6):811-819. PubMed ID: 33394542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
